Executive Director, Bioanalytical Development

Company Overview:

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.Learn more https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Role Summary:
The Executive Director, Head of Bioanalytical Development leads the bioanalytical capabilities and works on our programs to develop, validate, and implement robust PK and immunogenicity assays that allow accelerated transition from the bench to the clinic, from discovery throu...